Geratherm Medical AG (XTER:GME) ROCE % : -7.14% (As of Jun. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Geratherm Medical AG ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Geratherm Medical AG's annualized ROCE % for the quarter that ended in Jun. 2024 was -7.14%.

Geratherm Medical AG ROCE % Historical Data

The historical data trend for Geratherm Medical AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Geratherm Medical AG ROCE % Chart

Geratherm Medical AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

5.09

10.98

1.54

5.57

7.31

Geratherm Medical AG Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROCE %	Get a 7-Day Free Trial															7.38	4.59	9.72	3.98	-7.14

Geratherm Medical AG ROCE % Calculation

Geratherm Medical AG's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	2.476	/	( ( (38.38 - 0)	+	(35.719 - 6.336) )	/ 2 )
	=	2.476	/	( (38.38	+	29.383)	/ 2 )
	=	2.476	/	33.8815
	=	7.31 %

Geratherm Medical AG's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	-2.204	/	( ( (35.719 - 6.336)	+	(33.655 - 1.317) )	/ 2 )
	=	-2.204	/	( ( 29.383	+	32.338 )	/ 2 )
	=	-2.204	/	30.8605
	=	-7.14 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

Geratherm Medical AG (XTER:GME) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Geratherm Medical AG ROCE % Related Terms

Thank you for viewing the detailed overview of Geratherm Medical AG's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Geratherm Medical AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Geratherm Medical AG (XTER:GME) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

0EL9:UK

Address

Fahrenheitstrasse 1, Geratal, DEU, 99331

Website

https://www.geratherm.com

Geratherm Medical AG is a Germany-based medical technology company. The firm operates through four segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Healthcare Diagnostic segment which generates majority revenue provides analog and digital products for measuring body temperature, blood pressure monitors and other products for measuring temperature, as well as related accessories. Medical Warming Systems offers solutions for temperature management at all stages in the pre-clinical and clinical care of the patients, such as rescue situations and operations. Cardio/Stroke segment comprises products for preventing strokes. The Respiratory segment focuses on the development and production of products for pulmonary functional diagnostics.

Executives